Epithelial cyclooxygenase-2 expression: A model for pathogenesis of colon cancer

被引:26
作者
Arbabi, S [1 ]
Rosengart, MR [1 ]
Garcia, I [1 ]
Jelacic, S [1 ]
Maier, RV [1 ]
机构
[1] Univ Washington, Harborview Med Ctr, Dept Surg, Sch Med, Seattle, WA 98104 USA
关键词
cyclooxygenase (COX); colon; rectum; neoplasm; carcinoma; epithelium; signal transduction; mitogen-activated protein kinase (MAPK); osmolarity; lipopolysaccharide;
D O I
10.1006/jsre.2001.6112
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Recent studies indicate a close relationship between cyclooxygense-2 (COX-2) expression and the pathogenesis of colorectal cancer, yet little information exists regarding the stimuli and pathways involved in COX-2 expression by the colonic epithelium. We studied the induction of COX-2 in response to such environmental stress as hyperosmolarity and lipopolysaccharide (LPS) in a human colon cell line. We further investigated the transduction cascades mediating COX-2 expression, focusing upon the mitogen-activated protein kinase pathways p38 and extracellular signal-regulated kinase (ERK). Materials and methods. Human colon cancer cells (Caco-2) were stimulated with increasing concentrations of sodium chloride (NaCl) or LPS. Total protein was extracted at different time points and subjected to Western blot analysis with antibodies to human COX-2, COX-1, or phospho-specific antibodies to ERK and p38. Results. LPS failed to induce COX-2 or COX-1 expression. Hyperosmolarity induced COX-2 expression by 2 h, with peak levels occurring at 6-8 h. NaCl at 40 and 100 mM induced a 2-fold and more than 50-fold increase in COX-2 expression, respectively; COX-1 expression was not affected. Hyperosmolarity induced both p38 and ERK activation within 30 min; however, only p38 inhibition attenuated osmotic-induced COX-2 expression; inhibition of ERK activation had no effect. Conclusions. Increase in osmolarity activates p38 and induces COX-2 expression in the colonic epithelium. The lack of response to LPS is teleologically expected of the colonic epithelium that is in constant contact with the fecal bacteria. This model also pre-diets that an increase in luminal osmolarity in the colon may induce COX-2 and thereby promote a neoplastic phenotype. (C) 2001 Academic Press.
引用
收藏
页码:60 / 64
页数:5
相关论文
共 25 条
  • [11] Dannenberg AJ, 1999, SEMIN ONCOL, V26, P499
  • [12] p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes
    Dean, JLE
    Brook, M
    Clark, AR
    Saklatvala, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (01) : 264 - 269
  • [13] Differential expression of cyclooxygenase 2 in human colorectal cancer
    Dimberg, J
    Samuelsson, A
    Hugander, A
    Söderkvist, P
    [J]. GUT, 1999, 45 (05) : 730 - 732
  • [14] Fujita T, 1998, CANCER RES, V58, P4823
  • [15] A MAP KINASE TARGETED BY ENDOTOXIN AND HYPEROSMOLARITY IN MAMMALIAN-CELLS
    HAN, J
    LEE, JD
    BIBBS, L
    ULEVITCH, RJ
    [J]. SCIENCE, 1994, 265 (5173) : 808 - 811
  • [16] SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes
    Manthey, CL
    Wang, SW
    Kinney, SD
    Yao, ZB
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (03) : 409 - 417
  • [17] Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice
    Nakatsugi, S
    Fukutake, M
    Takahashi, M
    Fukuda, K
    Isoi, T
    Taniguchi, Y
    Sugimura, T
    Wakabayashi, K
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (12): : 1117 - 1120
  • [18] Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase
    Nemoto, S
    Xiang, JL
    Huang, S
    Lin, AN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) : 16415 - 16420
  • [19] Mitogen-activated protein kinase pathways
    Robinson, MJ
    Cobb, MH
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) : 180 - 186
  • [20] Prostacyclin (PGI(2)): New aspects of an old substance in the treatment of critically ill patients
    Scheeren, T
    Radermacher, P
    [J]. INTENSIVE CARE MEDICINE, 1997, 23 (02) : 146 - 158